Analyst Price Target is $28.45
▲ +30.62% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Fresenius Medical Care AG & Co. KGaA in the last 3 months. The average price target is $28.45, with a high forecast of $51.80 and a low forecast of $11.70. The average price target represents a 30.62% upside from the last price of $21.78.
Current Consensus is
Hold
The current consensus among 9 investment analysts is to hold stock in Fresenius Medical Care AG & Co. KGaA. This Hold consensus rating has held steady for over two years.
Fresenius Medical Care AG & Co. KgaA engages in the provision of products and services for individuals with renal diseases of which regularly undergo dialysis treatment. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the healthcare services business. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
Read More